Methamphetamine P NH2 anticorps

N° du produit ABIN487758

L’anticorps anti-Methamphetamine P NH2 Polyclonal Mouton est utilisé pour la détection de Methamphetamine P NH2. Il a été validé pour EIA.

Aperçu rapide pour Methamphetamine P NH2 anticorps (ABIN487758)

Antigène: Methamphetamine P NH2

Hôte: Mouton

Clonalité: Polyclonal

Application: Enzyme Immunoassay (EIA)

Détail du produit

Purification: Ig Fraction

Immunogène: Methamphetamine (p)-BSA

Isotype: IgG

Information d'application

Indications d'application: ELISA: , 2.5 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 9.72mg/mL (U.V. abs at 280nm)

Buffer: 20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2 containing 0.09 % Sodium Azide as preservative

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: -20 °C

Détail du antigène

Antigène: Methamphetamine P NH2

Autre désignation: Methamphetamine (P)

Classe de substances: Chemical

Sujet: Methamphetamine (METH) is closely related chemically to amphetamine (AMPH). METH is a potent central nervous system stimulant with additional peripheral sympathomimetic effects. METH and AMPH have been used clinically in the treatment of obesity, minimal brain dysfunction, narcolepsy, depression and to counter fatigue. They are also subjected to widespread abuse. METH is an indirect agonists. It causes the release of newly synthesized norepinephrine and dopamine and it blocks the re uptake of these transmitters from the synapse. This can lead to an increase in the concentration of catecholamines in the synapse as well as an overall increase in catecholaminergic activity in the brain. The mechanism of METH induced neurotoxicity for all monoaminergic cell types may lie primarily with the dopaminergic system in the striatum. It may also lie with the interaction between METH induced release of dopamine and its ability to inhibit monoamine oxidase.Synonyms: METH